The drug that DOES NOT result in theophylline toxicity is :
**Core Concept**
Theophylline is a methylxanthine used in the treatment of asthma and COPD. It is primarily metabolized by the liver enzyme CYP1A2, and its plasma levels can become toxic if not properly monitored.
**Why the Correct Answer is Right**
The correct answer is a drug that does not inhibit or induce the CYP1A2 enzyme, thereby not affecting theophylline levels. Theophylline toxicity is often due to interactions with other medications that alter its metabolism. A drug that does not interact with CYP1A2 would not contribute to theophylline toxicity.
**Why Each Wrong Option is Incorrect**
**Option A:** This drug is a potent inhibitor of CYP1A2, which would increase theophylline levels and lead to toxicity.
**Option B:** This drug is a known inducer of CYP1A2, which would decrease theophylline levels and potentially lead to subtherapeutic levels.
**Option C:** This drug is not a significant inhibitor or inducer of CYP1A2, but it can displace theophylline from plasma proteins, leading to increased free theophylline levels and toxicity.
**Clinical Pearl / High-Yield Fact**
When managing patients on theophylline, it is essential to consider potential interactions with other medications that may affect CYP1A2 activity, such as smoking, which can induce CYP1A2 and decrease theophylline levels.
**Correct Answer: C. This drug is not a significant inhibitor or inducer of CYP1A2, but it can displace theophylline from plasma proteins, leading to increased free theophylline levels and toxicity.**